FMCAX
Price
$44.55
Change
+$0.23 (+0.52%)
Updated
Jul 9 closing price
Net Assets
2.17B
VSEMX
Price
$241.50
Change
+$0.52 (+0.22%)
Updated
Jul 10 closing price
Net Assets
112.9B
Interact to see
Advertisement

FMCAX vs VSEMX

Header iconFMCAX vs VSEMX Comparison
Open Charts FMCAX vs VSEMXBanner chart's image
Fidelity Advisor Stock Selec Mid Cp M
Price$44.55
Change+$0.23 (+0.52%)
VolumeN/A
Net Assets2.17B
Vanguard Extended Market Index Instl Sel
Price$241.50
Change+$0.52 (+0.22%)
VolumeN/A
Net Assets112.9B
FMCAX vs VSEMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FMCAX vs. VSEMX commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMCAX is a Buy and VSEMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSEMX has more cash in the bank: 113B vs. FMCAX (2.17B). VSEMX pays higher dividends than FMCAX: VSEMX (1.17) vs FMCAX (0.07). FMCAX was incepted earlier than VSEMX: FMCAX (29 years) vs VSEMX (9 years). FMCAX (1.17) is less costly to investors than VSEMX (0.02). FMCAX is a more actively managed with annual turnover of: 52.00 vs. VSEMX (11.00). FMCAX has a lower initial minimum investment than VSEMX: FMCAX (0) vs VSEMX (3000000000). VSEMX annual gain was more profitable for investors over the last year : 17.22 vs. FMCAX (10.52). VSEMX return over 5 years is better than : 66.15 vs. FMCAX (46.50).
FMCAXVSEMXFMCAX / VSEMX
Total Expense Ratio1.170.025,850%
Annual Report Gross Expense Ratio1.170.025,850%
Fund Existence29 years9 years-
Gain YTD4.4794.223106%
Front Load4%N/A-
Min. Initial Investment03000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.17B113B2%
Annual Yield % from dividends0.071.176%
Returns for 1 year10.5217.2261%
Returns for 3 years23.7349.0148%
Returns for 5 years46.5066.1570%
Returns for 10 years33.62N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEQIX15.440.03
+0.19%
Glenmede Equity Income
LMORX40.45N/A
N/A
Patient Opportunity R
ATHDX31.04N/A
N/A
American Century Heritage R6
MSEPX22.79N/A
N/A
Morgan Stanley Inst Emerging Mkts C
BMIIX7.37N/A
N/A
BNY Mellon Income Stock I